Article Details
Retrieved on: 2018-04-14 20:45:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div><b>Renaissance Technologies</b> LLC cut its position in Concert Pharmaceuticals (NASDAQ:CNCE) by 5.7% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 358,200 shares of the biotechnology company's stock ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here